| Richard W Boersma, MD | |
|
10801 N Michigan Rd Ste 110, Zionsville, IN 46077-8171 | |
| (317) 344-1269 | |
| Not Available |
| Full Name | Richard W Boersma |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 10801 N Michigan Rd Ste 110, Zionsville, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558320051 | NPI | - | NPPES |
| IN01028548 | Other | IN | IN LIC # |
| 000000355597 | Other | IL | ANTHEM |
| 100216200 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01028548 (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Richard W Boersma, MD 10330 N Meridian St, Indianapolis, IN 46290-1024 Ph: () - | Richard W Boersma, MD 10801 N Michigan Rd Ste 110, Zionsville, IN 46077-8171 Ph: (317) 344-1269 |
News Archive
Social cognition and interaction training may improve certain aspects of social cognition and functioning in patients with affective disorders, results from a preliminary study suggest.
Eisai Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous t-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.
Researchers in a multi-institutional study led by Cincinnati Children's Hospital Medical Center slowed the growth of two particularly stubborn solid tumor cancers - neuroblastoma and peripheral nerve sheath tumors - without harming healthy tissues by inserting instructions to inhibit tissue growth into an engineered virus, according to study results published in the February 15 Cancer Research.
The German Lung Cancer Screening Intervention Trial shows that the early repeat scan rate for suspicious findings decreased by more than 80% with the second and subsequent low-dose computed tomography (LDCT) screens, but emphasizes the need to have an organized screening program with the baseline scan available for comparison.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced positive results from in vitro and in vivo studies assessing the efficacy of Restanza (cethromycin), its novel oral antibiotic, against the species of Plasmodium that cause malaria.
› Verified 2 days ago
Anthony R. Zabel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6866 W Stonegate Dr, Suite 100, Zionsville, IN 46077 Phone: 317-768-6000 Fax: 317-768-6015 | |
Michael W. Chapman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6085 Heartland Dr Ste 205, Zionsville, IN 46077 Phone: 317-768-2200 Fax: 317-768-2209 | |
Dr. Luis Felipe Romero-cortez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10801 N Michigan Rd, Zionsville, IN 46077 Phone: 317-344-1234 | |
Dr. Hao D Yan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10801 N Michigan Rd Ste 110, Zionsville, IN 46077 Phone: 317-344-1269 | |
Chandra Lee Ostrognai, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 51 N Ford Rd, Zionsville, IN 46077 Phone: 317-973-3333 | |
Michelle Mccarthy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 W Oak St Ste 101, Zionsville, IN 46077 Phone: 317-733-6300 Fax: 317-733-6315 | |
Jessica L Swenberg, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Brendon Way, Suite 800, Zionsville, IN 46077 Phone: 317-777-6400 Fax: 317-777-6410 |